abstract |
The present invention relates to β-adrenergic agonists for the treatment of diseases / symptoms such as obesity and diabetes. The compound has the following general formula (1).n n n n n n n n Wherein R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , W, X, Y and Z are as defined in the specification. |